KV
Kambhampati Vani Kumari
About Kambhampati Vani Kumari
Data last updated:
Kambhampati Vani Kumari is a Director at Vivit Pharma India Private Limited (since 2014). The companies operate in Chemicals. Earlier, Kambhampati Vani Kumari was a Director at Raghavendhra Pharma Private Limited (2013–2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vivit Pharma India Private Limited U24240TG2014PTC095864 | Director | 29 Sep 2014 | 2014 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Raghavendhra Pharma Private Limited U24232TG2012PTC081027 | Director | 28 Feb 2013 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kambhampati Vani Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravi Kambhampati Kumar | 06967094 | Vivit Pharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kambhampati Vani Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kambhampati Vani Kumari
Kambhampati Vani Kumari currently holds 1 directorship: Vivit Pharma India Private Limited (Director, since 29 Sep 2014).
Kambhampati Vani Kumari was first appointed on 28 Feb 2013 as Director at Raghavendhra Pharma Private Limited. The most recent appointment on record is 29 Sep 2014 at Vivit Pharma India Private Limited.
Kambhampati Vani Kumari held 1 earlier board appointment: Raghavendhra Pharma Private Limited (Director, 28 Feb 2013 to 21 Aug 2015).
The current boards of Kambhampati Vani Kumari's companies include Ravi Kambhampati Kumar (Vivit Pharma India Private Limited).